Pharmaceutical & API manufacturing sites in Switzerland

110 drug establishments in Switzerland are registered with the US FDA; 41 (37%) list API manufacture among their operations. 85 registrant companies are identified, 8 of them with more than one API site here; sites whose registrant is not resolved to a company profile are not counted. 75 published sites are matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
110
Registered for API manufacture
41
Identified registrants
85
Current EU/UK GMP match
75

Registered operations

Analytical testing76
Drug manufacture59
API manufacture41
Labelling30
Packaging30
Repackaging5
Sterilisation4
Particle size reduction3
Relabelling3

A site can register several operations, so these do not add up to the site total.

Companies headquartered in Switzerland

API manufacturing sites (41)

Other sites with EU/UK GMP documents (44)

All 85 published sites in Switzerland, A–Z

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.